Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD
NCT02357576
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
22
Enrollment
OTHER
Sponsor class
Conditions
Cholestasis
Interventions
DRUG:
Intralipid 20% I.V. Fat Emulsion
Sponsor
University of Michigan
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]